Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzaran
      6. Gustavo A. Alcocer
      7. Jose Ignacio De Santiago
      8. Alejandro Luna
      9. Alonso Camargo
      10. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Varinia Calleros
      6. Abraham Diaz
      7. Georgina Flores
      8. Pedro Herrera
      9. Carlos Maya
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
      7. Carlos Woodworth
    4. All Attorneys / Engineers
    5. Firm Administration
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. Use requirements
        2. Approach to composite marks changed, again
        3. Life Sciences Handbook 2011 - Country Q&A
        4. Mexico should accept secondary meaning
        5. Getting the Deal Through - Trademarks 2011
        6. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        7. No legal basis for banning names derived from INNs
        8. How Latin America tackles cutting-edge IP issues
        9. Specialised IP court corrects IMPI
        10. Protecting trade dress
        11. 43 more items...
      2. Patent Law Articles
        1. Mexico issues regulations to approve biologic drugs
        2. Latin America Roundtable
        3. New regulations pending
        4. The International Comparative Guide
        5. Marketing authorization for pharmaceutical
        6. Approval of follow-on biologics in Mexico
        7. Mexican Linkage Gazette April 2011
        8. Patent Prosecution Highway in Mexico
        9. Life Sciences Handbook 2011 - Country Q&A
        10. Data Package Exclusivity (DPE)
        11. 35 more items...
      3. Copyright Law Articles
        1. Advertising in social media networks
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 100 more items...
      4. Corporate Law Articles
        1. Mexico issues Personal Data Protection Rules
        2. How data affects innovation
        3. A practical cross-border
        4. New registry for security interests
        5. The International Comparative Legal Guide to: Merger Control 2011
        6. The International Comparative Legal Guide to: Merger Control 2010
        7. Due diligence issues to consider in M&A
        8. Income expectations in licensing
        9. The reasons for valuation
        10. Amendments proposed to franchise regulation
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Amendments to the Federal Law for Consumer Protection
        2. Mexico issues Personal Data Protection Rules
        3. New Regulations Pending
        4. Marketing authorization for pharmaceutical products to foreign applicants
        5. Data Package Exclusivity (DPE)
        6. Supreme Court upholds the worth of formulation patents
        7. Pharmaceutical trademarks
        8. Framework for biotherapeutic products established
        9. Pharmaceutical Advertising 2009
        10. New Regulations for pharma industry
        11. 3 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Whither Rental Rights?
        2. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Presumed Guilty - How can a law firm help win an Emmy?
      2. New rules came in force to speed timeframes in administrative appeal proceedings
      3. Recent reforms to the Mexican Industrial Property Law dealing with trademark priority rights
      4. Olivares & Cia. ranking
      5. Data Package Exclusivity (DPE)
      6. Mr. Sergio Olivares Sr's Passing
      7. Pharma Linkage Regulations Supreme Court Decision
      8. Managing IP magazine has recognized Olivares & Cia. as the leading firm for patent work in Mexico
      9. Mexican Congress amends the Patent Law
      10. Implementation of the Federal Law for the Protection of Personal Data in Possession of Private Entities
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » Knowledge & Resources » Articles » Trademark Law Articles » Mexico should accept secondary meaning

Mexico should accept secondary meaning

by Carlos A. Reyes

Managing Intellectual Property, March 2011
According to Article 153 of the Mexican Industrial Property Law, a mark can be cancelled from the register when it has become in trade and for relevant consumers, the usual name of the products or services it was registered for. This referenced provision regulates the case of marks that – by acquiring of fame and the tolerance of its owner – becomes the usual or generic name of a product or service in trade.
In this regard, it is contradictory that Mexican Law – accepting that distinctiveness can be lost – does not have any express regulation about the acquisition of distinctiveness by use. This lack of positive national regulations implies that secondary meaning is not admitted as an argument for trade mark registration by our Industrial Property Office (IMPI), even if TRIPs states in Article 15 that the members – of which Mexico is one – may condition trade mark registration of non-distinctive signs to the acquisition of distinctiveness by use. So even if a descriptive mark had been used in Mexican trade by one single producer, so long and so exclusively that it had developed secondary meaning to all relevant consumers – referring to a clearly identified origin – IMPI does not consider it in its decisions, arguing the lack of national written regulations.
But distinctiveness can actually be acquired by use in trade, and in fact every day weak trademarks become highly distinctive as a consequence of their use in trade. So distinctiveness is not immutable and can be lost as well as acquired. This is why we believe that by application of TRIPs Article 15, Mexico should incorporate and accept secondary meaning in order to allow the registration of descriptive signs that have acquired distinctiveness by use.